About 15,950 children and adolescents receive a cancer diagnosis each year in the United States. The global figure reached an estimated 397,000 new cases in the most recent count available. Five-year survival now stands at 86 percent for all childhood cancers combined in the United States, though rates remain near 20 percent in low-income countries.
Key Takeaways
- In the United States, about 15,950 children and adolescents (ages 0-19 years) are diagnosed with cancer each year
- In 2022, approximately 1,650 children and adolescents died from cancer in the US (ages 0-19)
- GWAS identified 30+ risk loci for pediatric ALL susceptibility
- The 5-year survival rate for all childhood cancers combined in the US is 86.2% (2014-2020, ages 0-19)
- Chemotherapy cures 80-90% of childhood ALL cases
Childhood cancer remains uncommon but can be treated successfully in many cases, especially when detected early.
Related reading
01 · Category
Incidence and Prevalence30 stats
01
In the United States, about 15,950 children and adolescents (ages 0-19 years) are diagnosed with cancer each year
02
Globally, an estimated 397,000 children and adolescents (0-19 years) developed cancer in 2020
03
Childhood cancer incidence rate in the US is 17.9 per 100,000 children and adolescents aged 0-19 years (2017-2021)
04
In Europe, the annual incidence of childhood cancer is approximately 35 per million children under 15 years
05
In the UK, around 1,900 children and young people (0-24 years) are diagnosed with cancer annually
06
Australia's childhood cancer incidence rate is 16.3 per 100,000 for ages 0-14 years (2014-2018)
07
In Canada, 1,050 children under 15 are diagnosed yearly, rate of 17.2 per 100,000
08
Brazil reports 8,000-10,000 new childhood cancer cases annually for ages 0-19
09
In India, childhood cancer comprises 5.4% of all cancers, with ~50,000 new cases yearly
10
South Africa's childhood cancer incidence is 140 per million children under 15
11
In Japan, 2,500 children under 15 are diagnosed annually, rate 14.2 per 100,000
12
China's estimated 80,000-100,000 new childhood cancer cases per year (0-14 years)
13
In low- and middle-income countries, 90% of childhood cancer cases occur
14
US Black children have a 20% higher incidence rate of childhood cancer than White children (ages 0-19)
15
Incidence of childhood cancer peaks at ages 2-3 years globally
16
In the US, leukemia accounts for 27% of childhood cancers (0-19 years)
17
Brain and CNS tumors represent 26% of childhood cancers in the US
18
Lymphoma comprises 12% of US childhood cancers (0-19)
19
Neuroblastoma incidence: 700 cases/year in US children under 15
20
Wilms tumor: ~500 new cases annually in US children
21
Retinoblastoma: 200-300 cases/year in US (ages 0-4 peak)
22
Incidence rate for ALL in US children 0-14: 3.4 per 100,000
23
In Europe, embryonal tumors incidence 2.5 per million under 15
24
US Hispanic children have highest rate of ALL: 4.2 per 100,000 (0-19)
25
Global prevalence of childhood cancer survivors: 500,000 worldwide
26
In France, 2,200 new cases/year in children 0-18, rate 186 per million
27
Nigeria reports incidence rate of 4.7 per 100,000 under 15
28
In the US, thyroid cancer incidence in adolescents rising 4.3% annually
29
Global childhood cancer incidence projected to rise 78% by 2050 to 707,000 cases
30
Mexico's childhood cancer rate: 15.6 per 100,000 (0-19 years)
Interpretation
Incidence and Prevalence Interpretation
A sobering parade of numbers reveals childhood cancer as a global scourge, striking with cruel statistical consistency from the U.S. to Nigeria yet shrouded in stark inequities of access and outcome.
02 · Category
Mortality Rates and Impact30 stats
01
In 2022, approximately 1,650 children and adolescents died from cancer in the US (ages 0-19)
02
Global childhood cancer deaths: over 100,000 annually, representing 11% of cancer deaths
03
US childhood cancer mortality rate: 2.3 per 100,000 (2017-2021, 0-19 years)
04
Leukemia accounts for 24% of childhood cancer deaths in US
05
Brain/CNS tumors: 27% of US childhood cancer deaths
06
Decline in US childhood cancer mortality: 60% since 1970 (from 6.5 to 2.3 per 100k)
07
In low-income countries, 9 out of 10 childhood cancer deaths occur
08
UK childhood cancer mortality halved since 1980s to ~250 deaths/year
09
Australia: 40 childhood cancer deaths/year (0-14), rate 0.7 per 100k
10
Canada: ~140 cancer deaths/year in children under 20
11
Brazil: ~3,000 childhood cancer deaths annually
12
India: ~35,000 childhood cancer deaths per year
13
China's childhood cancer mortality rate: 5.3 per 100,000 (0-14)
14
Africa: 92% of childhood cancer patients die due to lack of treatment
15
US Black children cancer mortality 33% higher than White (2017-21)
16
Infant cancer mortality US: higher at 5.0 per 100k vs 2.1 for 1-19 years
17
AML causes 31% of leukemia deaths in US children
18
Bone cancer mortality US children: 1.3 per million under 20
19
Soft tissue sarcoma mortality: 4.6% of childhood cancer deaths US
20
Global projection: childhood cancer deaths to increase 86% by 2050
21
In Europe, childhood cancer mortality declined 3.5% annually (1990-2016)
22
Nigeria: childhood cancer mortality rate 3.9 per 100k under 15
23
Mexico: 2,500 cancer deaths/year in children 0-19
24
Japan: childhood cancer deaths 500/year, survival gains reduced mortality 40%
25
South Africa: ~400 childhood cancer deaths annually
26
US neuroblastoma mortality: 19.5% of cases (2014-20)
27
Retinoblastoma mortality in US: <1%, mostly extraocular
28
70-80% of childhood cancer patients experience late effects post-treatment
29
Economic burden of childhood cancer in US: $113,095per patient first year
30
Lifetime risk of second malignancy for survivors: 10-20%
Interpretation
Mortality Rates and Impact Interpretation
While we've cut childhood cancer mortality by over half in wealthy nations since the 1970s, the staggering global toll—where a child's survival still depends largely on their birthplace—is a moral failure that future progress must urgently rectify.
03 · Category
Risk Factors and Causes15 stats
01
GWAS identified 30+ risk loci for pediatric ALL susceptibility
02
Down syndrome increases leukemia risk 20-30 fold in children
03
Ionizing radiation exposure pre-conception raises childhood cancer risk 1.4-2x
04
Parental smoking associated with 10-20% increased leukemia risk in offspring
05
Li-Fraumeni syndrome: 50% lifetime cancer risk, 25% childhood onset
06
Beckwith-Wiedemann syndrome: 7-10% risk of embryonal tumors like Wilms
07
No strong link to cell phone use; <1% attributable risk for brain tumors
08
Pesticide exposure increases ALL risk by 40% in some studies
09
Prior chemotherapy raises secondary cancer risk 4-6 fold
10
Boys have 12% higher incidence of childhood cancer than girls globally
11
Twins have 2-3x higher concordance for childhood cancer
12
HIV infection increases NHL risk 100-fold in children
13
EBV associated with 50% endemic Burkitt lymphoma cases
14
Neurofibromatosis type 1: 5-10% risk of optic glioma
15
Family history doubles risk for neuroblastoma in siblings
Interpretation
Risk Factors and Causes Interpretation
While these statistics paint a grim mosaic of vulnerability, they also provide a crucial map for targeting prevention and genetic vigilance where it matters most.
More related reading
04 · Category
Survival Rates and Outcomes30 stats
01
The 5-year survival rate for all childhood cancers combined in the US is 86.2% (2014-2020, ages 0-19)
02
US acute lymphoblastic leukemia (ALL) 5-year survival: 91.1% for children under 20 (2014-2020)
03
Survival for US childhood Hodgkin lymphoma: 98.0% at 5 years (2014-2020)
04
Brain and other CNS cancers 5-year survival in US children: 71.5% (2014-2020)
05
Non-Hodgkin lymphoma 5-year survival US children: 88.4% (2014-2020)
06
Neuroblastoma 5-year survival US: 80.5% (2014-2020, under 15)
07
Wilms tumor 5-year survival: 93.8% in US children (2014-2020)
08
Retinoblastoma survival: 99.3% 5-year in US (localized)
09
Globally, childhood cancer survival in high-income countries averages 80%
10
In low-income countries, survival rate for childhood cancer is about 20%
11
UK childhood cancer 5-year survival improved to 84% (2010-2011 cohort)
12
Australia's 5-year survival for childhood cancer: 85% (2014-2018)
13
Canada childhood leukemia survival: 90% 5-year (recent data)
14
In Europe, 10-year survival for childhood cancer: 81% (1982-2016 cohorts)
15
US infant leukemia survival: 68.3% 5-year (under 1 year)
16
Adolescent (15-19) cancer survival US: 85.4% 5-year vs 87.7% for 0-14
17
Boys have slightly lower survival than girls for childhood cancer (84.6% vs 86.1% US 5-year)
18
Black children US survival for all cancers: 82.3% 5-year vs 86.9% White (2014-2020)
19
Hispanic children US cancer survival: 85.0% 5-year (2014-2020)
20
ALL survival improved from 87.3% (2004-10) to 91.1% (2014-20) in US children
21
CNS tumor survival in US adolescents: 74.2% 5-year (15-19 years)
22
Ewing sarcoma 5-year survival US: 70.8% (localized 82.4%)
23
Rhabdomyosarcoma survival: 65.8% 5-year US children
24
In Brazil, childhood cancer survival: 65% overall
25
India reports 5-year survival for ALL: 50-60% in major centers
26
Japan childhood cancer 5-year survival: 82.9% (2006-2008)
27
South Africa survival for childhood cancer: ~50%
28
Global St. Jude Global initiative aims to raise LMIC survival to 60% by 2030
29
US AML 5-year survival children: 69.3% (2014-2020)
30
Thyroid cancer survival in US children/adolescents: 99.8% 5-year
Interpretation
Survival Rates and Outcomes Interpretation
Our odds are improving—with survival rates for many childhood cancers now impressively high—but the unconscionable gulf between outcomes for the rich and the poor starkly reminds us this is a battle won by resources, not just medicine.
05 · Category
Treatment and Therapies17 stats
01
Chemotherapy cures 80-90% of childhood ALL cases
02
Radiation therapy used in 20-30% of childhood cancer cases globally
03
Surgery is primary treatment for 50% of solid childhood tumors
04
CAR-T cell therapy approved for pediatric ALL refractory cases (2017)
05
Imatinib (Gleevec) revolutionized CML treatment in children, >90% response
06
Proton beam therapy reduces long-term effects by 50% vs traditional radiation
07
HSCT success rate for high-risk neuroblastoma: 40-50%
08
Multidrug regimens cure 85% Wilms tumor with actinomycin/vincristine
09
Retinoblastoma treated with intra-arterial chemo saves 90% eyes
10
Bispecific antibodies like blinatumomab: 44% complete remission in relapsed B-ALL
11
80% of children with Hodgkin lymphoma cured with ABVD chemo + radiation
12
TKIs like larotrectinib for NTRK fusion cancers: 75% response rate
13
Immunotherapy checkpoint inhibitors trialed in 15% pediatric solid tumors
14
Clinical trials enroll 60% US childhood cancer patients at diagnosis
15
Supportive care like BMT for AML: 60% long-term survival post-transplant
16
Targeted therapy for ALK in neuroblastoma: 80% response in relapsed
17
Neoadjuvant chemo shrinks 70% rhabdomyosarcoma tumors pre-surgery
Interpretation
Treatment and Therapies Interpretation
The relentless march of medical science, armed with scalpels, targeted molecules, and immune cells reprogrammed like tiny assassins, has turned a landscape of grim prognosis into a complex but hopeful battlefield where we are steadily trading blunt force for precision in the fight to save children.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Lars Eriksen. (2026, February 13). Child Cancer Statistics. Gitnux. https://gitnux.org/child-cancer-statistics
MLA
Lars Eriksen. "Child Cancer Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/child-cancer-statistics.
Chicago
Lars Eriksen. 2026. "Child Cancer Statistics." Gitnux. https://gitnux.org/child-cancer-statistics.
Sources & references
17 datasets cited across this report · attribution is report-level